QIAGEN N.V.: Release of a capital market information

DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Buyback QIAGEN N.V.: Release of a capital market information 22.01.2019 / 11:41 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting With disclosure dated December 19, 2018, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a third tranche of up to USD 70 million under the share repurchase program originally announced on January 31, 2018. The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from January 14, 2018 until and including January 18, 2019 amounts to 126,207 shares. Shares were bought back as follows: Date Number of Shares Average Price Purchased Volume acquired (EUR) (EUR) 14- January 25,650 31.3450 803,999.25 -2019 15- January 25,550 31.4673 803,989.52 -2019 16- January 25,119 32.0067 803,976.30 -2019 17- Janaury 25,018 32.1357 803,970.94 -2019 18- January 24,870 32.3280 803,997.36 -2019 Total 126,207 31.8159 4,019,933.36 The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from December 19, 2018 until and including January 18, 2019 amounts to 517,502 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 22 January 2019 Managing Board ### Contacts: QIAGEN QIAGEN Investor Relations John Gilardi [phone] e-mail: [e-mail] Public Relations Dr. Thomas Theuringer [phone] e-mail: [e-mail] 22.01.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	QIAGEN N.V.
	Hulsterweg 82
	5912 PL Venlo
	Netherlands
Internet:	www.qiagen.com

End of News	DGAP News Service

768397  22.01.2019